GDUFA Research Outcomes
PBPK Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to physiologically-based pharmacokinetics (PBPK) computational modeling to support generic product development and assessment.
-
Formulation Considerations for Selecting an Appropriate RLD or RS
Kim, Timothy H
-
Utilizing Modelling Approaches to Support Regulatory Submission for Orally Inhaled Drug Products: Case Example
Kelly, Marc
-
General Considerations for the Quantitative Sameness Evaluation of a Proposed Generic Formulation
Kaviratna, Anubhav
-
Key Aspects in Developing Appropriate IVRT Methods for Topical Generic Products: Advances and Challenges
Kapanadze, Theo
-
A Multiscale Framework For Computational Inhalation Pharmacology
Kannan, Ravi; Chen, Z J; Singh, Narendra; Przekwas, Andrzekj; Delvadia, Renishkumar; Tian, Geng
-
Prediction of Respimat� Inhaler Spray: Co-Flow Air Behavior
Kakhi, Maziar
-
PBPK Models: Opportunities for Enhancements
Jusko, William
-
Overview of Complex Generics Regulatory Perspective on Bioequivalence
Jiang, Jeff
-
PBPK Modeling to Support Risk Assessment for Oral Drug Products, Including Waiver of Fed BE Studies
Jereb, Rebeka
-
PBPK Modeling for Different Locally-Administered Drug Products
Jereb, Rebeka